Status:
NOT_YET_RECRUITING
Chromotubation on the Remaining Fallopian Tube After a Laparoscopic Salpingectomy Due to Tubal Pregnancy
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Ectopic Pregnancy
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
Ectopic pregnancy prevalence is approximately 1-2% of all pregnancies, majority of which located in the fallopian tube. Among the risk factors for ectopic pregnancy is tubal factor - meaning a mechani...
Detailed Description
Ectopic pregnancy occurs approximately in 1-2% of all pregnancies. The risk is higher among patients with risk factors such as previous ectopic pregnancy, history of pelvic inflammatory disease, endom...
Eligibility Criteria
Inclusion
- Patients undergoing laparoscopic salpingectomy for tubal ectopic pregnancy.
Exclusion
- Patients with a history of unilateral salpingectomy
- Patients with suspected heterotopic pregnancy
- Patients with suspected allergic reaction to blue dye injection
Key Trial Info
Start Date :
September 30 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06554964
Start Date
September 30 2024
End Date
September 1 2025
Last Update
October 8 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.